INS and type 2 diabetes mellitus: Changes in key glycemic outcomes, insulin doses, and BMI from baseline to weeks 12 and 24 in the GEMINI-T2Da study, which evaluated the efficacy of a web-based, algorithm-guided insulin titration system in adults with insulin-treated type 2 diabetes at the Singapore General Hospital from September 2020 to May 2022. P values indicate trends over the study period.